Logo image of SB.CA

STRATABOUND MINERALS CORP (SB.CA) Stock Fundamental Analysis

TSX-V:SB - TSX Venture Exchange - CA86268E3032 - Common Stock - Currency: CAD

0.03  0 (0%)

Fundamental Rating

0

Overall SB gets a fundamental rating of 0 out of 10. We evaluated SB against 818 industry peers in the Metals & Mining industry. SB may be in some trouble as it scores bad on both profitability and health. SB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SB had negative earnings in the past year.
SB had a negative operating cash flow in the past year.
In the past 5 years SB always reported negative net income.
In the past 5 years SB always reported negative operating cash flow.
SB.CA Yearly Net Income VS EBIT VS OCF VS FCFSB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -1M -2M -3M

1.2 Ratios

SB has a better Return On Assets (-6.15%) than 69.04% of its industry peers.
Looking at the Return On Equity, with a value of -7.99%, SB is in the better half of the industry, outperforming 68.43% of the companies in the same industry.
Industry RankSector Rank
ROA -6.15%
ROE -7.99%
ROIC N/A
ROA(3y)-10.08%
ROA(5y)-9.66%
ROE(3y)-11.99%
ROE(5y)-11.4%
ROIC(3y)N/A
ROIC(5y)N/A
SB.CA Yearly ROA, ROE, ROICSB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 1K 2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SB.CA Yearly Profit, Operating, Gross MarginsSB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for SB has been increased compared to 1 year ago.
SB has a worse debt/assets ratio than last year.
SB.CA Yearly Shares OutstandingSB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
SB.CA Yearly Total Debt VS Total AssetsSB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

2.2 Solvency

SB has an Altman-Z score of -0.77. This is a bad value and indicates that SB is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SB (-0.77) is worse than 62.65% of its industry peers.
SB has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
SB has a Debt to Equity ratio of 0.19. This is in the lower half of the industry: SB underperforms 72.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z -0.77
ROIC/WACCN/A
WACCN/A
SB.CA Yearly LT Debt VS Equity VS FCFSB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 0.23 indicates that SB may have some problems paying its short term obligations.
SB has a Current ratio of 0.23. This is amonst the worse of the industry: SB underperforms 85.14% of its industry peers.
A Quick Ratio of 0.23 indicates that SB may have some problems paying its short term obligations.
SB's Quick ratio of 0.23 is on the low side compared to the rest of the industry. SB is outperformed by 83.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
SB.CA Yearly Current Assets VS Current LiabilitesSB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.67% over the past year.
EPS 1Y (TTM)53.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%155.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SB.CA Yearly Revenue VS EstimatesSB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 500 1K 1.5K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SB.CA Price Earnings VS Forward Price EarningsSB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SB.CA Per share dataSB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06 0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STRATABOUND MINERALS CORP

TSX-V:SB (3/20/2024, 7:00:00 PM)

0.03

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.24%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.59M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.15%
ROE -7.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-10.08%
ROA(5y)-9.66%
ROE(3y)-11.99%
ROE(5y)-11.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20521.5%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z -0.77
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%155.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y47.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.16%
OCF growth 3YN/A
OCF growth 5YN/A